Alfhili MA, Nkany MB, Weidner DA, Lee MH
References Qiu, C
Obviously we're doing all the time, but this is when we repair, when our hormones replete
suppression of TNF--induced inflammatory cytokine secretion
A woman on a stable HRT regimen who adds CJC-1295 with Ipamorelin is not duplicating treatment, she is layering two protocols that target different physiology
The practical takeaway: Injection = high systemic distribution tendons, ligaments, muscle, joints, vascular tissue Oral = high local GI concentration intestinal lining, gastric mucosa, gut repair Nasal = intermediate systemic delivery potential neurological targeting, emerging evidence only Injectable BPC-157: Highest Bioavailability for Systemic and Musculoskeletal Goals Injectable BPC-157 is the best-studied delivery method for healing applications outside the gastrointestinal tract